# Elevance Health, Inc.: insider transactions

ELV · NYSE · CIK 1156039 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/elv.md) · [Financials](/companies/elv/financials.md) · [Filings](/companies/elv/filings.md) · [Insiders](/companies/elv/insiders.md)

## All transactions: 13

Non-derivative transactions reported on Forms 4, newest first. Codes P (purchase) and S (sale) are open-market trades. Reported price is as stated on the form, not a market price. Filter with ?type= `open-market`, `purchase`, `sale`.

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-22 | [Kaye Mark](/insiders/1748691.md) | EVP & CFO, Officer | Sale (S) | 273 | $447.19 | $122.1k | [Form 4](/filings/0001748691-26-000008.md) |
| 2026-10-22 | [Kaye Mark](/insiders/1748691.md) | EVP & CFO, Officer | Sale (S) | 827 | $446.05 | $368.9k | [Form 4](/filings/0001748691-26-000008.md) |
| 2026-10-22 | [Kaye Mark](/insiders/1748691.md) | EVP & CFO, Officer | Sale (S) | 160 | $444.85 | $71.2k | [Form 4](/filings/0001748691-26-000008.md) |
| 2026-10-22 | [Kaye Mark](/insiders/1748691.md) | EVP & CFO, Officer | Sale (S) | 440 | $443.81 | $195.3k | [Form 4](/filings/0001748691-26-000008.md) |
| 2026-10-22 | [Kaye Mark](/insiders/1748691.md) | EVP & CFO, Officer | Sale (S) | 480 | $442.61 | $212.5k | [Form 4](/filings/0001748691-26-000008.md) |
| 2026-10-22 | [Kaye Mark](/insiders/1748691.md) | EVP & CFO, Officer | Sale (S) | 2,343 | $441.34 | $1.0m | [Form 4](/filings/0001748691-26-000008.md) |
| 2026-10-22 | [Kaye Mark](/insiders/1748691.md) | EVP & CFO, Officer | Sale (S) | 1,720 | $440.44 | $757.6k | [Form 4](/filings/0001748691-26-000008.md) |
| 2026-10-22 | [Kaye Mark](/insiders/1748691.md) | EVP & CFO, Officer | Sale (S) | 1,160 | $439.25 | $509.5k | [Form 4](/filings/0001748691-26-000008.md) |
| 2026-10-22 | [Kaye Mark](/insiders/1748691.md) | EVP & CFO, Officer | Sale (S) | 240 | $438.22 | $105.2k | [Form 4](/filings/0001748691-26-000008.md) |
| 2026-10-22 | [Kaye Mark](/insiders/1748691.md) | EVP & CFO, Officer | Sale (S) | 560 | $437.07 | $244.8k | [Form 4](/filings/0001748691-26-000008.md) |
| 2026-10-22 | [Kaye Mark](/insiders/1748691.md) | EVP & CFO, Officer | Sale (S) | 1,660 | $436.20 | $724.1k | [Form 4](/filings/0001748691-26-000008.md) |
| 2026-10-22 | [Kaye Mark](/insiders/1748691.md) | EVP & CFO, Officer | Sale (S) | 321 | $435.25 | $139.7k | [Form 4](/filings/0001748691-26-000008.md) |
| 2026-10-22 | [Kaye Mark](/insiders/1748691.md) | EVP & CFO, Officer | Sale (S) | 400 | $434.00 | $173.6k | [Form 4](/filings/0001748691-26-000008.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.